1,1-dichloroethene increases expression ISO RGD:1616832 6480464 vinylidene chloride results in increased expression of SHCBP1 mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of SHCBP1 mRNA CTD PMID:30723492 17alpha-ethynylestradiol affects expression ISO RGD:1616832 6480464 Ethinyl Estradiol affects the expression of SHCBP1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO RGD:1616832 6480464 Ethinyl Estradiol results in increased expression of SHCBP1 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1354140 6480464 Estradiol results in increased expression of SHCBP1 mRNA CTD PMID:18310284 more ... 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1616832 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1616832 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1616832 6480464 Tetrachlorodibenzodioxin results in increased expression of SHCBP1 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1616832 6480464 Tetrachlorodibenzodioxin affects the expression of SHCBP1 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1354140 6480464 Tetrachlorodibenzodioxin results in decreased expression of SHCBP1 mRNA CTD PMID:20106945 2,4-diaminotoluene increases expression ISO RGD:1616832 6480464 2, 4-diaminotoluene results in increased expression of SHCBP1 mRNA CTD PMID:20713471 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of SHCBP1 mRNA CTD PMID:17109745 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1354140 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SHCBP1 mRNA CTD PMID:28628672 3-methylcholanthrene increases expression ISO RGD:1616832 6480464 Methylcholanthrene results in increased expression of SHCBP1 mRNA CTD PMID:20713471 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SHCBP1 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression ISO RGD:1616832 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SHCBP1 mRNA CTD PMID:18648102 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SHCBP1 mRNA CTD PMID:24780913 aflatoxin B1 affects expression ISO RGD:1354140 6480464 Aflatoxin B1 affects the expression of SHCBP1 protein CTD PMID:20106945 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of SHCBP1 mRNA CTD PMID:17109745 azathioprine decreases expression ISO RGD:1354140 6480464 Azathioprine results in decreased expression of SHCBP1 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:1354140 6480464 Benzo(a)pyrene results in decreased expression of SHCBP1 mRNA CTD PMID:20064835 benzo[a]pyrene decreases expression ISO RGD:1616832 6480464 Benzo(a)pyrene results in decreased expression of SHCBP1 mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO RGD:1354140 6480464 Benzo(a)pyrene results in increased expression of SHCBP1 mRNA CTD PMID:20106945 , PMID:22316170 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1354140 6480464 7 more ... CTD PMID:20018196 , PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1616832 6480464 benzo(b)fluoranthene results in increased expression of SHCBP1 mRNA CTD PMID:26377693 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of SHCBP1 mRNA CTD PMID:17109745 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SHCBP1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1354140 6480464 bisphenol A results in decreased expression of SHCBP1 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:1354140 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SHCBP1 mRNA CTD PMID:28628672 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of SHCBP1 mRNA CTD PMID:25993096 calcitriol multiple interactions ISO RGD:1354140 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SHCBP1 mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:1354140 6480464 Calcitriol results in decreased expression of SHCBP1 mRNA CTD PMID:21592394 carbon nanotube affects expression ISO RGD:1616832 6480464 Nanotubes, Carbon affects the expression of SHCBP1 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1616832 6480464 Nanotubes, Carbon analog results in increased expression of SHCBP1 mRNA CTD PMID:25554681 chloropicrin increases expression ISO RGD:1354140 6480464 chloropicrin results in increased expression of SHCBP1 mRNA CTD PMID:26352163 , PMID:28476498 choline multiple interactions ISO RGD:1616832 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SHCBP1 mRNA CTD PMID:20938992 cisplatin multiple interactions ISO RGD:1354140 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SHCBP1 mRNA, Cisplatin promotes the reaction [Piroxicam results in increased expression of SHCBP1 mRNA] CTD PMID:21858171 , PMID:27392435 cisplatin decreases expression ISO RGD:1354140 6480464 Cisplatin results in decreased expression of SHCBP1 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:1354140 6480464 Cisplatin results in increased expression of SHCBP1 mRNA CTD PMID:27594783 cobalt dichloride decreases expression ISO RGD:1354140 6480464 cobaltous chloride results in decreased expression of SHCBP1 mRNA CTD PMID:19376846 copper atom increases expression ISO RGD:1616832 6480464 Copper results in increased expression of SHCBP1 mRNA CTD PMID:17205981 copper(0) increases expression ISO RGD:1616832 6480464 Copper results in increased expression of SHCBP1 mRNA CTD PMID:17205981 copper(II) sulfate decreases expression ISO RGD:1354140 6480464 Copper Sulfate results in decreased expression of SHCBP1 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1354140 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1354140 6480464 Coumestrol results in increased expression of SHCBP1 mRNA CTD PMID:19167446 cyclosporin A affects expression ISO RGD:1354140 6480464 Cyclosporine affects the expression of SHCBP1 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:1354140 6480464 Cyclosporine results in decreased expression of SHCBP1 mRNA CTD PMID:21632981 DDT decreases expression ISO RGD:1354140 6480464 DDT results in decreased expression of SHCBP1 mRNA CTD PMID:25014179 dexamethasone multiple interactions ISO RGD:1354140 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SHCBP1 mRNA CTD PMID:28628672 dibenz[a,h]anthracene increases expression ISO RGD:1616832 6480464 1 more ... CTD PMID:26377693 dioxygen decreases expression ISO RGD:1354140 6480464 Oxygen deficiency results in decreased expression of SHCBP1 mRNA CTD PMID:26516004 Enterolactone multiple interactions ISO RGD:1354140 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHCBP1 mRNA CTD PMID:19167446 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of SHCBP1 mRNA CTD PMID:24412560 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of SHCBP1 mRNA CTD PMID:24412560 folic acid multiple interactions ISO RGD:1616832 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SHCBP1 mRNA CTD PMID:20938992 folic acid multiple interactions ISO RGD:1354140 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of SHCBP1 mRNA CTD PMID:24657277 furan increases expression EXP 6480464 furan results in increased expression of SHCBP1 mRNA CTD PMID:25539665 hydrogen peroxide affects expression ISO RGD:1354140 6480464 Hydrogen Peroxide affects the expression of SHCBP1 mRNA CTD PMID:21179406 indometacin multiple interactions ISO RGD:1354140 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SHCBP1 mRNA CTD PMID:28628672 kojic acid increases expression ISO RGD:1354140 6480464 kojic acid results in increased expression of SHCBP1 mRNA CTD PMID:16595896 L-methionine multiple interactions ISO RGD:1616832 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SHCBP1 mRNA CTD PMID:20938992 lucanthone decreases expression ISO RGD:1354140 6480464 Lucanthone results in decreased expression of SHCBP1 mRNA CTD PMID:21148553 MeIQx increases expression ISO RGD:1354140 6480464 2-amino-3 more ... CTD PMID:20816883 methamphetamine decreases expression ISO RGD:1354140 6480464 Methamphetamine results in decreased expression of SHCBP1 mRNA CTD PMID:25290377 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of SHCBP1 mRNA CTD PMID:28341135 methotrexate multiple interactions ISO RGD:1354140 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of SHCBP1 mRNA CTD PMID:24657277 methotrexate decreases expression ISO RGD:1354140 6480464 Methotrexate results in decreased expression of SHCBP1 mRNA CTD PMID:24657277 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of SHCBP1 mRNA CTD PMID:25380136 ozone multiple interactions ISO RGD:1616832 6480464 [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of SHCBP1 mRNA, TTPA protein affects the reaction [Ozone results in increased expression of SHCBP1 mRNA] CTD PMID:19555225 , PMID:25658374 ozone increases expression ISO RGD:1616832 6480464 Ozone results in increased expression of SHCBP1 mRNA CTD PMID:25658374 paracetamol increases expression ISO RGD:1354140 6480464 Acetaminophen results in increased expression of SHCBP1 mRNA CTD PMID:22230336 phenethyl isothiocyanate decreases expression ISO RGD:1354140 6480464 phenethyl isothiocyanate results in decreased expression of SHCBP1 mRNA CTD PMID:26678675 phenobarbital multiple interactions ISO RGD:1616832 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SHCBP1 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:1616832 6480464 Phenobarbital affects the expression of SHCBP1 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:1616832 6480464 Phenobarbital results in increased expression of SHCBP1 mRNA CTD PMID:19482888 , PMID:20403969 phytoestrogen increases expression ISO RGD:1354140 6480464 Phytoestrogens results in increased expression of SHCBP1 mRNA CTD PMID:18310284 pirinixic acid increases expression ISO RGD:1616832 6480464 pirinixic acid results in increased expression of SHCBP1 mRNA CTD PMID:18301758 , PMID:23811191 piroxicam multiple interactions ISO RGD:1354140 6480464 Cisplatin promotes the reaction [Piroxicam results in increased expression of SHCBP1 mRNA] CTD PMID:21858171 piroxicam increases expression ISO RGD:1354140 6480464 Piroxicam results in increased expression of SHCBP1 mRNA CTD PMID:21858171 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1616832 6480464 Pregnenolone Carbonitrile results in increased expression of SHCBP1 mRNA CTD PMID:22698814 progesterone increases expression ISO RGD:1354140 6480464 Progesterone results in increased expression of SHCBP1 mRNA CTD PMID:18070364 progesterone decreases expression ISO RGD:1354140 6480464 Progesterone results in decreased expression of SHCBP1 mRNA CTD PMID:21795739 propanal decreases expression ISO RGD:1354140 6480464 propionaldehyde results in decreased expression of SHCBP1 mRNA CTD PMID:26079696 resveratrol multiple interactions ISO RGD:1354140 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of SHCBP1 mRNA CTD PMID:19167446 silicon dioxide decreases expression ISO RGD:1354140 6480464 Silicon Dioxide analog results in decreased expression of SHCBP1 mRNA CTD PMID:23806026 sodium arsenite decreases expression ISO RGD:1616832 6480464 sodium arsenite results in decreased expression of SHCBP1 mRNA CTD PMID:17998272 sodium arsenite increases expression ISO RGD:1354140 6480464 sodium arsenite results in increased expression of SHCBP1 mRNA CTD PMID:29301061 tamoxifen affects expression ISO RGD:1616832 6480464 Tamoxifen affects the expression of SHCBP1 mRNA CTD PMID:17555576 testosterone multiple interactions ISO RGD:1354140 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SHCBP1 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1354140 6480464 Testosterone results in decreased expression of SHCBP1 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:1616832 6480464 Carbon Tetrachloride affects the expression of SHCBP1 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1616832 6480464 Carbon Tetrachloride results in increased expression of SHCBP1 mRNA CTD PMID:27339419 , PMID:29987408 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SHCBP1 mRNA CTD PMID:23411599 titanium dioxide increases expression ISO RGD:1616832 6480464 titanium dioxide results in increased expression of SHCBP1 mRNA CTD PMID:23557971 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of SHCBP1 mRNA CTD PMID:30012374 titanium dioxide affects expression ISO RGD:1616832 6480464 titanium dioxide affects the expression of SHCBP1 mRNA CTD PMID:17656681 trichloroethene increases expression ISO RGD:1616832 6480464 Trichloroethylene results in increased expression of SHCBP1 mRNA CTD PMID:25549359 trimellitic anhydride increases expression ISO RGD:1616832 6480464 trimellitic anhydride results in increased expression of SHCBP1 mRNA CTD PMID:19042947 valproic acid increases expression ISO RGD:1354140 6480464 Valproic Acid results in increased expression of SHCBP1 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid decreases expression ISO RGD:1354140 6480464 Valproic Acid results in decreased expression of SHCBP1 mRNA CTD PMID:28001369 zaragozic acid A decreases expression ISO RGD:1616832 6480464 squalestatin 1 results in decreased expression of SHCBP1 mRNA CTD PMID:27225895 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of SHCBP1 mRNA CTD PMID:27225895 
Gene-Chemical Interaction Annotations
